Human interleukin-10 expression in T/natural killer-cell lymphomas: Association with anaplastic large cell lymphomas and nasal natural killer- cell lymphomas

American Journal of Pathology

Volumn 153, Issue 4, 1998, Pages 1229-1237

  Boulland, Marie Laure ^a   Meignin, Véronique ^a,b   Leroy Viard, Karen ^a   Copie Bergman, Christiane ^a   Brière, Josette ^c   Touitou, Robert ^d   Kanavaros, Panagiotis ^e   Gaulard, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c Hopital Laennec   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA;

ANAPLASTIC CARCINOMA; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; LARGE CELL LYMPHOMA; MALE; NATURAL KILLER CELL; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL;

EID: 0031667786     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65667-2     Document Type: Article

References (39)

1. Hsu SM, Waldron JW, Hsu PL, Hough AJ: Cytokines in malignant lymphomas: review and perspective evaluation. Hum Pathol 1993, 24:1040-1057
2. Pistoia V: Production of cytokines by human B cell in health and disease. Immunol Today 1997, 18:343-350
3. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84:1361-1392
4. Gaulard P, Bourquelot P, Kanavaros P, Haioun C, Le Couedic JP, Divine M, Goossens M, Zafrani ES, Farcet JP, Reyes F: Expression of the α/β and γ/δ T-cell receptors in 57 cases of peripheral T-cell lymphomas: identification of a subset of γδ T-cell lymphomas. Am J Pathol 1990, 137:617-628
5. Foss HD, Anagnostopoulos I, Herbst H, Grebe M, Ziemann K, Hummel M, Stein H: Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1995, 10:2862-2869
6. Merz H, Houssiau FA, Orscheschek K, Renauld JC, Fliedner A, Herin M, Noel H, Kadin M, Mueller-Hermelink HK, Van Snick J, Feller AC: Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 1991, 5:1311-1317
7. Merz H, Fliedner A, Orscheschek K, Binder T, Sebald W, Müller-Hermelink HK, Feller AC: Cytokine expression in T-cell lymphomas and Hodgkin's disease: its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. Am J Pathol 1991, 139:1173-1180
8. Fiorentino DF, Bond MW, Mosmann TF: Two types of mouse helper T-cells: Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989, 170:2081-2095
9. Suda T, O'Garra A, MacNeil I, Fischer MD, Bond M, Zlotnik A: Identification of a novel thymocyte growth promoting factor from B-cell lymphomas. Cell Immunol 1990, 129:228-240
10. Howard M, O'Garra A, Ishida H, de Waal Malefyt R, de Vries J: Biological properties of interleukin-10. J Clin Immunol 1992, 12:239-247
11. Vieira P, De Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, De Vries JE, Roncarolo MG, Mosmann TR, Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 1991, 88:1172-1176
12. MacNeil IA, Suda T, Moore KW, Mosmann TR, Zlotnik A: IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 1990, 145:4167-4173
13. Roussel F, Garcia E, Defrance T, Péronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J: Interleukin 10 is a potent growth, and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992, 89:1890-1893
14. Chen WF, Zlotnik A: IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 1991, 147:528-534
15. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991, 174:1209-1220
16. Warren HS, Kinnear BF, Kastelein RL, Lanier LL: Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells. J Immunol 1996, 156:3254-3259
17. Benjamin D, Knobloch TJ, Dayton MA: Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 1992, 80:1289-1298
18. Masood R, Zhang Y, Bond MW, Scadden DT, Moudgil T, Law RE, Kaplan MH, Jung B, Espina BM, Lunardi-Iskandar Y, Levine AM, Gill PS: Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood 1995, 85:3423-3430
19. Emilie D, Touitou R, Raphael M, Peuchmaur M, Devergne O, Rea D, Coumbraras J, Crevon MC, Edelman L, Joab I, Galanaud P: In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol 1992, 22:2937-2942
20. Mori N, Gill PS, Moudgil T, Murakawi S, Eto S, Prager D: Interleukin-10 gene expression in adult T-cell leukemia. Blood 1996, 88:1035-1045
21. Boulland ML, Kanavaros P, Wechsler J, Casiraghi O, Gaulard P: Cytotoxic protein expression in natural-killer cell lymphomas and in αβ and γδ peripheral T-cell lymphomas. J Pathol 1997, 183:432-439
22. Emile JF, Boulland ML, Haouin C, Kanavaros P, Petrella T, Delfau-Larue MH, Bensussan A, Farcet JP, Gaulard P: CD5-, CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996, 87:1466-1473
23. Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kelenyi G, Sundstrom C, Lennert K, van Unnick J, Mioduszewska O, Wright D: Updated Kiel classification for lymphomas. Lancet 1988, 1:292-293
24. Lechner F, Vogt H-R, Seow H, Bertoni G, Cheevers WP, von Bodungen U, Zurbriggen A, Peterhans E: Expression of cytokine mRNA in lentivirus-induced arthritis. Am J Pathol 1997, 151:1053-1065
25. Kanavaros P, Lescs MC, Brière J, Divine M, Galateau F, Joab I, Bosq J, Farcet JP, Reyes F, Gaulard P: Nasal T-cell lymphoma: a clinico-pathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993, 81:2688-2695
26. Yagi H, Tokura Y, Furukawa F, Takigawa M: Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-γ. J Invest Dermatol 1996, 107:827-832
27. Liu Y, Wei SHY, Ho ASY, de Waal Malefyt R, Moore KW: Expression, cloning, and characterization of a human IL-10 receptor. J Immunol 1994, 152:1821-1829
28. Taga K, Tosato G: IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992, 148:1143-1148
29. Taga K, Mostowski H, Tosato G: Human Interleukin-10 can directly inhibit T-cell growth. Blood 1993, 81:2964-2971
30. Brunetti M, Martelli N, Colasante A, Piantelli M, Musiani P, Aiello F: Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. Blood 1995, 86:4199-4205
31. Foss HD, Anagnostopoulos I, Araujo I, Assaf C, Demel G, Kummer JA, Hummel M, Stein H: Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996, 88:4005-4011
32. Krenacs L, Wellmann A, Himmelmann AW, Bagdi E, Jaffe ES, Raffeld M: Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T-and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 1997, 89:980-989
33. Felgar RE, Macon WR, Kinney MC, Roberts S, Pasha T, Salhany KE: TIA-1 expression in lymphoid neoplasms: identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Am J Pathol 1997, 150:1893-1900
34. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor CG, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (IL-10), and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991, 174:915-924
35. Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci M, Kiessling R: Interleukin 10 pretreatment protects target cells from tumor-, and allo-specific cytotoxic T cells, and down regulates HLA class I expression. J Exp Med 1994, 180:2371-2376
36. Schlaak JF, Hermann E, Gallati H: Meyer zum Büschenfelde K-H, Fleischer B: Differential effects of IL-10 on proliferation and cytokine production of human γ/δ and α/β T cells. Scand J Immunol 1994, 39:209-215
37. Lundqvist C, Melgar S, Mo-Wai Yeung M, Hammarström S, Hammarström M-L: Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions. J Immunol 1996, 157:1926-1934
38. Carson WE, Lindemann MJ, Baiocchi R, Linett M, Tan JC, Chou CC, Narula S, Caligiuri MA: The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 1995, 85:3577-3585
39. Herbst H, Foss HD, Samol J, Araujo I, Klotzbach H, Krause H, Agathanggelou A, Niedobhitek G, Stein H: Frequent expression of interleukin-10 by Epstein-Barr virus harboring tumor cells of Hodgkin's disease Blood 1996, 87:2918-2929